WNG-PBE.03.2019/185
Support for the export activities of AronPharma sp. z o. o. through participation in the Vitafoods Europe Trade Fair in 2020
Total Project Cost: 112,797.21 PLN
Requested Funding Amount from European Funds (EFRR): 55,685.12 PLN
The purpose of participating in the project is to increase the recognition of AronPharma and establish business connections with potential partners from selected foreign markets. Both of these goals will directly impact the company's operations in international markets by acquiring business partners.
The company's main business objective is to introduce new products, which have not yet been present on international markets, based on dry extracts from berry fruits, particularly chokeberry extract, and their mixtures, developed through its own research efforts.
These objectives will be achieved by participating as an exhibitor at the Vitafoods Europe trade fair in May 2020 in Geneva, Switzerland. This is the largest global B2B trade fair for food supplements, nutraceuticals, and active natural substances.
Given the applicant's business model and focus primarily on exporting its products, attending this trade fair and building the company's image as a solid and enduring company focused on quality and long-term processes and collaboration is highly important.
WNG-PBE.03.2019/186
Support for the export activities of AronPharma sp. z o. o. through participation in the Vitafoods Europe Trade Fair in 2021
Total Project Cost: 120 451,04 PLN
Requested Funding Amount from European Funds (EFRR): 59 133,02 PLN
Here's the translation of the provided text from Polish to English:
The purpose of participating in the project is to increase the recognition of AronPharma and establish business connections with potential partners from selected foreign markets. Both of these goals will directly impact the company's operations in international markets by acquiring business partners.
The company's main business objective is to introduce new products, which have not yet been present on international markets, based on dry extracts from berry fruits, particularly chokeberry extract, and their mixtures, developed through its own research efforts.
This goal will be achieved by participating as an exhibitor at the Vitafoods Europe trade fair in 2021 in Geneva, Switzerland. This is the largest global B2B trade fair for food supplements, nutraceuticals, and active natural substances.
Given the applicant's business model and focus primarily on exporting its products, attending this trade fair and building the company's image as a solid and enduring company focused on quality and long-term processes and collaboration is highly important.
WNG-PBE.03.2019/187
Support for orocesses related to the promotion and export of products and services of AronPharma Sp. z o.o. through participation in trade missions as a component of business development.
Total Project Cost: 70 998,30 PLN
Requested Funding Amount from European Funds (EFRR): 34 819,50 PLN
The purpose of participating in the project is to increase the recognition of AronPharma Sp. z o.o. and establish business connections with potential partners from selected foreign markets. Both of these goals will directly impact the company's operations in international markets by acquiring business partners.
The company's main business objective is to introduce new products, which have not yet been present on international markets, based on dry extracts from berry fruits, particularly chokeberry extract, and their mixtures, developed through its own research efforts.
These objectives will be achieved through the following actions:
Action 1: CPHI Worldwide, Frankfurt, November 5-7, 2019
Action 2: Fi Europe & Ni 2019, Paris, December 3-5, 2019
Action 3: Supply Side East, Meadowlands Exposition Center – Secaucus, NJ, USA, April 21-22, 2020
Action 4: Health Ingredients (Hi)/CPhI Korea, August 26-28, 2020
Action 5: Vitafoods Asia, Singapore, September 2020
Action 6: CPHI Worldwide, Milan, Italy; October 13-15, 2020
Action 7: Supply Side West, Las Vegas, USA, November 2020
Action 8: Health Ingredients (Hi) Europe, Frankfurt, Germany, December 1-3, 2020
Action 9: Supply Side East, USA, April 2021
Action 10: CPHI Worldwide, October 2021 (Paris/Barcelona/Madrid/Frankfurt/Milan)
WNG-PBE.05.2021/074
Support for the export activities of AronPharma Sp. z o.o. through participation in the Natural Products Expo West 2022 and CPHI 2022 trade fairs.
Total project cost: 180 234,58 PLN
Requested funding amount from European funds (EFRR): 79 965,47 PLN
The goal of participating in the project is to increase the recognition of AronPharma, establish and strengthen business connections with potential partners from selected foreign markets. Both of these objectives will directly impact the company's operations in international markets by acquiring business partners and building long-term economic relationships with them.
The company's main business objective is to continue introducing new, previously unavailable products to international markets, based on dry extracts from berry fruits, particularly chokeberry extract, and their mixtures developed through in-house research. The proposed products, especially chokeberry and combinations with various extracts and functional substrates (e.g., probiotics, vitamins, minerals), aim to fill a niche that appears to exist for such products.
The objectives outlined above will be achieved through participation as an exhibitor at the Natural Products Expo West 2022 in Anaheim, CA, USA, and CPHI 2022 in Frankfurt, Germany. These are among the largest global B2B trade fairs for food supplements, nutraceuticals, pharmaceuticals, and natural active substances. Given the applicant’s business model, which is primarily focused on exporting its products, attending these trade fairs and building the company's image as a reliable and enduring entity that values quality and long-term processes and partnerships is crucial.
Additionally, participating in the trade fair in the USA—the world's largest dietary supplement market—creates new opportunities for product sales through collaboration with distributors.
WNG-PBE.07.2023/053
Support for the export activities of AronPharma Sp. z o.o. through participation in the Vitafoods Asia 2023 and CPHI 2023 Expo trade fairs.
Total project cost: 187 975,55 PLN
Requested funding amount from European funds (EFRR): 79 867,99 PLN
The goal of participating in the project is to increase the recognition of AronPharma, establish, and strengthen business relationships with potential partners from selected foreign markets. Both of these objectives will directly impact the company's operations in international markets by acquiring business partners and building long-term economic relationships with them.
The company's main business objective is to continue introducing new, previously unavailable products to international markets, based on extracts from various plants with significant biological potential, as well as on liposomal forms of vitamins and minerals, developed through in-house research. The proposed products, particularly those with synergistic effects, such as chokeberry combined with other plants and functional substrates (e.g., probiotics, vitamins, minerals), aim to fill a niche that appears to exist for such products—especially for eye care products (Retico®) and diabetic products (Forminol™).
The objectives outlined in this section will be achieved by participating as an exhibitor at Vitafoods Asia 2023 in Bangkok, Thailand (September 20-22, 2023), and CPHI 2023 in Barcelona, Spain (October 24-26, 2023). These are some of the largest global B2B trade fairs for food supplements, nutraceuticals, pharmaceuticals, and natural active substances.
Considering the applicant's business model, which is primarily focused on exporting its products, attending these trade fairs and building the company's image as a reliable and enduring entity that values quality and long-term processes and partnerships is highly important. A key factor in selecting these trade events is also their location in Europe and Asia, as these markets are currently the priority for the company's export development.